Lung disease experts at Johns Hopkins have made a call for greater caution for prescribing inhaled corticosteroids to people suffering from chronic obstructive pulmonary disease (COPD). The call came after sufficient evidence was found by the experts that inhaled corticosteroids enhance the risk of pneumonia by a full third.
It is believed that more than 11 million Americans are living with COPD and a vast majority of this population belongs to the former or current smokers' category.
From News-Medical.Net:
Despite the increased pneumonia risk, the team found no clear evidence that the drug therapy also pushes up rates for other steroid-related problems, such as bone fractures, nor was there an increase in deaths.
Senior study investigator and critical care specialist Eddy Fan, M.D., says the results of the analysis should not alarm patients or cause them to stop taking their medications but should spur physicians to screen and monitor their patients to find the lowest possible steroid dose that works, especially in the elderly, people with immune system problems, and people who have had multiple bouts of pneumonia and for whom repeat bacterial infection might be a life-threatening complication.
"Inhaled corticosteroids are not of equal benefit to all, and what we are seeing is that the treatment may be more harmful and pose a greater risk of harm to some," says Fan, an instructor at the Johns Hopkins University School of Medicine.
According to pulmonologist M. Brad Drummond, M.D., M.H.S., who led the study, the findings are seen to serve as a reminder for all those people with serious lung disease to take steps for ensuring a reduction concerned with chances of getting pneumonia, which doubles their risk of dying.
Posts
No comments:
Post a Comment